Capricor Therapeutics
CAPR
CAPR
37 hedge funds and large institutions have $19.9M invested in Capricor Therapeutics in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
5% more capital invested
Capital invested by funds: $18.9M → $19.9M (+$952K)
8.27% less ownership
Funds ownership: 21.48% → 13.21% (-8.3%)
Holders
37
Holding in Top 10
–
Calls
$1.36M
Puts
$455K
Top Buyers
| 1 | +$4.45M | |
| 2 | +$541K | |
| 3 | +$507K | |
| 4 |
JF
Jump Financial
Chicago,
Illinois
|
+$258K |
| 5 |
Morgan Stanley
New York
|
+$258K |
Top Sellers
| 1 | -$9.54M | |
| 2 | -$185K | |
| 3 | -$166K | |
| 4 |
Millennium Management
New York
|
-$116K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$71.3K |